National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
92.41
-0.76 (-0.82%)
Mar 28, 2025, 4:00 PM EST - Market closed
National HealthCare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,252 | 1,088 | 1,029 | 965.54 | 931.8 | Upgrade
|
| Other Revenue | 46.18 | 47.7 | 45.2 | 45.4 | 46.13 | Upgrade
|
| Revenue | 1,298 | 1,135 | 1,074 | 1,011 | 977.93 | Upgrade
|
| Revenue Growth (YoY) | 14.32% | 5.68% | 6.26% | 3.38% | -1.85% | Upgrade
|
| Cost of Revenue | 810.93 | 712.34 | 686.17 | 666.06 | 605.77 | Upgrade
|
| Gross Profit | 487.01 | 422.97 | 388.11 | 344.88 | 372.16 | Upgrade
|
| Selling, General & Admin | 43.18 | 41.53 | 40.98 | 40.82 | 40.49 | Upgrade
|
| Other Operating Expenses | 321.39 | 288.18 | 289.37 | 266.75 | 275.16 | Upgrade
|
| Operating Expenses | 406.56 | 371.74 | 370.84 | 348.24 | 357.67 | Upgrade
|
| Operating Income | 80.45 | 51.23 | 17.27 | -3.37 | 14.49 | Upgrade
|
| Interest Expense | -4.14 | -0.32 | -0.56 | -0.85 | -1.4 | Upgrade
|
| Interest & Investment Income | 18.08 | 14.65 | 10.66 | 11.62 | 13.99 | Upgrade
|
| Earnings From Equity Investments | 0.59 | 2.02 | 0.48 | 5.11 | 12.34 | Upgrade
|
| EBT Excluding Unusual Items | 94.98 | 67.56 | 27.85 | 12.52 | 39.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | 31.98 | 14.94 | -15.81 | 82.38 | -22.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 6.23 | - | - | 2.78 | Upgrade
|
| Asset Writedown | - | - | - | -8.23 | - | Upgrade
|
| Other Unusual Items | 9.45 | - | 15.19 | 63.36 | 32.28 | Upgrade
|
| Pretax Income | 136.41 | 88.74 | 27.23 | 150.04 | 52.42 | Upgrade
|
| Income Tax Expense | 34.32 | 23.45 | 7.25 | 10.95 | 10.43 | Upgrade
|
| Earnings From Continuing Operations | 102.09 | 65.29 | 19.98 | 139.09 | 41.99 | Upgrade
|
| Minority Interest in Earnings | -0.16 | 1.51 | 2.47 | -0.5 | -0.12 | Upgrade
|
| Net Income | 101.93 | 66.8 | 22.45 | 138.59 | 41.87 | Upgrade
|
| Net Income to Common | 101.93 | 66.8 | 22.45 | 138.59 | 41.87 | Upgrade
|
| Net Income Growth | 52.59% | 197.61% | -83.80% | 230.99% | -38.62% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 1.44% | -0.45% | 0.20% | 0.31% | 0.06% | Upgrade
|
| EPS (Basic) | 6.62 | 4.36 | 1.46 | 9.03 | 2.74 | Upgrade
|
| EPS (Diluted) | 6.53 | 4.34 | 1.45 | 8.99 | 2.72 | Upgrade
|
| EPS Growth | 50.46% | 199.31% | -83.87% | 230.51% | -38.74% | Upgrade
|
| Free Cash Flow | 79.7 | 83.32 | -21.46 | 23 | 181.39 | Upgrade
|
| Free Cash Flow Per Share | 5.11 | 5.42 | -1.39 | 1.49 | 11.80 | Upgrade
|
| Dividend Per Share | 2.420 | 2.340 | 2.260 | 2.110 | 2.080 | Upgrade
|
| Dividend Growth | 3.42% | 3.54% | 7.11% | 1.44% | 0.97% | Upgrade
|
| Gross Margin | 37.52% | 37.26% | 36.13% | 34.12% | 38.06% | Upgrade
|
| Operating Margin | 6.20% | 4.51% | 1.61% | -0.33% | 1.48% | Upgrade
|
| Profit Margin | 7.85% | 5.88% | 2.09% | 13.71% | 4.28% | Upgrade
|
| Free Cash Flow Margin | 6.14% | 7.34% | -2.00% | 2.27% | 18.55% | Upgrade
|
| EBITDA | 122.44 | 93.26 | 57.76 | 37.31 | 56.51 | Upgrade
|
| EBITDA Margin | 9.43% | 8.21% | 5.38% | 3.69% | 5.78% | Upgrade
|
| D&A For EBITDA | 41.99 | 42.03 | 40.49 | 40.67 | 42.02 | Upgrade
|
| EBIT | 80.45 | 51.23 | 17.27 | -3.37 | 14.49 | Upgrade
|
| EBIT Margin | 6.20% | 4.51% | 1.61% | -0.33% | 1.48% | Upgrade
|
| Effective Tax Rate | 25.16% | 26.43% | 26.64% | 7.30% | 19.90% | Upgrade
|
| Revenue as Reported | 1,307 | 1,142 | 1,086 | 1,074 | 1,028 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.